Response to recent announcement

Home Reit

15/07/2025 07:00

RNS Number : 0180R

Home REIT PLC

15 July 2025

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

 

15 July 2025

Home REIT plc

("HOME" or the "Company")

Response to announcement re AlTi RE Limited and Alvarium Fund Managers (UK) Limited entering administration

 

The Board of Home REIT notes the recent announcement that AlTi RE Limited and Alvarium Fund Managers Limited have entered administration. As previously announced, the Board has issued pre-action letters of claim to Alvarium Fund Managers (UK) Limited (its former alternative investment fund manager), AlTi RE Limited (its former investment adviser's principal) and Alvarium Home REIT Advisors Limited (in liquidation) (its former investment adviser). The Company is in contact with the administrators. The Company cannot comment any further on these issues at this stage as to do so may prejudice the Company's position in any potential proceedings.

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

FTI Consulting (Communications Adviser)
Dido Laurimore
Bryn Woodward
Oliver Harrison
HomeREIT@fticonsulting.com
+44 (0)20 3727 1000

 

The Company's LEI is: 213800A53AOVH3FCGG44.

 

For more information, please visit the Company's website: www.homereituk.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
RSPFFFSLDTISLIE